Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Tuñón

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|March 20, 2012
Phosphate: a stealthier killer than previously thought?Emilio Gonzalez-Parra, Jose Tuñón, Jesus Egido, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2012
Vitamin D receptor activation and cardiovascular diseaseEmilio Gonzalez-Parra, Jorge Rojas-Rivera, Jose Tuñón, et al.
Current Vascular Pharmacology|June 26, 2012
Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data CMelina Vega de Céniga, Luis M Blanco-Colio, Jose Tuñón, et al.
European Journal of Pharmacology|July 30, 2002
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cellsMónica Ortego, Almudena Gómez Hernández, Carmen Bustos, et al.
Journal of Cardiovascular Pharmacology|April 12, 2005
HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cellsMonica Ortego, Almundena Gómez-Hernández, Cristina Vidal, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 27, 2020
Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomesMarta López-Castillo, Álvaro Aceña, Ana M Pello-Lázaro, et al.
Journal of Proteome Research|August 9, 2005
Quest for novel cardiovascular biomarkers by proteomic analysisFernando Vivanco, Jose L Martín-Ventura, Mari Carmen Duran, et al.
European Journal of Pharmacology|March 6, 2007
Atorvastatin modulates the profile of proteins released by human atherosclerotic plaquesM Carmen Durán, Jose L Martín-Ventura, Shabaz Mohammed, et al.
Journal of Clinical Medicine|September 14, 2024
Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot StudyAndrea Camblor Blasco, Ana Devesa, Luis Nieto Roca, et al.
Journal of Clinical Medicine|October 28, 2023
Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective StudyMarcelino Cortés, Oscar Lorenzo, Jairo Lumpuy-Castillo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|March 20, 2012
Phosphate: a stealthier killer than previously thought?Emilio Gonzalez-Parra, Jose Tuñón, Jesus Egido, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2012
Vitamin D receptor activation and cardiovascular diseaseEmilio Gonzalez-Parra, Jorge Rojas-Rivera, Jose Tuñón, et al.
Current Vascular Pharmacology|June 26, 2012
Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data CMelina Vega de Céniga, Luis M Blanco-Colio, Jose Tuñón, et al.
European Journal of Pharmacology|July 30, 2002
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cellsMónica Ortego, Almudena Gómez Hernández, Carmen Bustos, et al.
Journal of Cardiovascular Pharmacology|April 12, 2005
HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cellsMonica Ortego, Almundena Gómez-Hernández, Cristina Vidal, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 27, 2020
Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomesMarta López-Castillo, Álvaro Aceña, Ana M Pello-Lázaro, et al.
Journal of Proteome Research|August 9, 2005
Quest for novel cardiovascular biomarkers by proteomic analysisFernando Vivanco, Jose L Martín-Ventura, Mari Carmen Duran, et al.
European Journal of Pharmacology|March 6, 2007
Atorvastatin modulates the profile of proteins released by human atherosclerotic plaquesM Carmen Durán, Jose L Martín-Ventura, Shabaz Mohammed, et al.
Journal of Clinical Medicine|September 14, 2024
Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot StudyAndrea Camblor Blasco, Ana Devesa, Luis Nieto Roca, et al.
Journal of Clinical Medicine|October 28, 2023
Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective StudyMarcelino Cortés, Oscar Lorenzo, Jairo Lumpuy-Castillo, et al.
Pageof 2